Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “lung cancer”

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)Recruiting
NCT06095583Phase 3Updated Jul 27, 2026
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Limited-stage Small Cell Lung Cancer (LS-SCLC)
China, Georgia, Netherlands, Spain, Taiwan +1 more
Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung CancerCompleted
NCT05348668Phase 2Updated Jul 27, 2026
Sponsor: Anhui Provincial Hospital
Non-Small Cell Lung Cancer
China
Mesothelin-targeted CAR T-cell Therapy in Patients With MesotheliomaActive Not Recruiting
NCT04577326Phase 1Updated Jul 27, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Malignant Pleural Mesothelioma (MPM)
United States
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic AlterationsRecruiting
NCT06772623Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: AbbVie
Non Small Cell Lung Carcinoma
United States, Belgium, China, France, Germany +9 more
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung CancerRecruiting
NCT05198830Phase 2Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Lung Adenocarcinoma · Lung Large Cell Carcinoma · Lung Non-Squamous Non-Small Cell Carcinoma · Stage III Lung Cancer AJCC v8
United States
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint InRecruiting
NCT06745908Phase 3Updated Jul 27, 2026
Sponsor: ImmunityBio, Inc.
NSCLC Stage IV
United States, Canada, United Kingdom
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung CancerSuspended
NCT05642195Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Non-Small Cell Lung Cancer · Non-Small Cell Lung Carcinoma · Carcinoma, Non-Small-Cell Lung · Carcinomas
United States
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLCRecruiting
NCT07491497Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: TRIANA Biomedicines, Inc.
ALK-positive NSCLC · ALK-Positive Lung Cancer · ALK-positive Non-small Cell Lung Cancer
United States
Effects of Infusion Timing on Treatment Response in Solid TumorsNot Yet Recruiting
NCT07630168Phase 2Updated Jul 27, 2026
Sponsor: UNC Lineberger Comprehensive Cancer Center
Lung Cancer · Non-small Cell Lung Cancer · Metastatic Lung Cancer · Head and Neck Cancer
United States
IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung CancerRecruiting
NCT07122687Phase 2Updated Jul 27, 2026
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
China
Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 NegativeSuspended
NCT04929041Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Lung Adenocarcinoma · Lung Adenosquamous Carcinoma · Lung Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8
United States
Evaluating Respiratory Effects of Driving Pressure Guided Mechanical Ventilation Using Electrical Impedance Tomography in Patients Undergoing Robot-Assisted Laparoscopic Radical ProstatectomyCompleted
NCT06540794NAUpdated Jul 27, 2026
Sponsor: Istanbul University
Prostate Cancer · Lung Protective Ventilation · Postoperative Pulmonary Complications
Turkey (Türkiye)
A First-in-human (FIH), Open-Label, Dose Escalation and Expansion Cohorts Study of MC002Not Yet Recruiting
NCT07726212Phase 1Updated Jul 27, 2026
Sponsor: Hangzhou MacroLink Biopharmaceutical LLC
Advanced Esophageal Cancer · Advanced Lung Cancer
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialRecruiting
NCT06096844Phase 3Updated Jul 24, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Lung Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8 · Stage IIIC Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8
United States
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CPRecruiting
NCT07354074Phase 2Updated Jul 24, 2026
Sponsor: Novartis Pharmaceuticals
Chronic Myelogenous Leukemia · Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
United States, Australia, Canada, China, France +6 more
Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS TrialRecruiting
NCT07176000NAUpdated Jul 24, 2026
Sponsor: Fred Hutchinson Cancer Center
Lung Carcinoma
United States
Centralization and Oncologic Outcomes in Ovarian CancerRecruiting
NCT07075939N/AUpdated Jul 24, 2026
Sponsor: Azienda USL Reggio Emilia - IRCCS
Epithelial Ovarian Cancer · Ovarian Neoplasms · Advanced Ovarian Cancer
Italy
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Recruiting
NCT06568939Phase 2Updated Jul 24, 2026
Sponsor: AbbVie
Non-Small Cell Lung Cancer
United States, Brazil, China, Israel, Japan +2 more
Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)Active Not Recruiting
NCT01696994NAUpdated Jul 24, 2026
Sponsor: National Cancer Institute (NCI)
Ovarian Carcinoma · Ovarian Germ Cell Tumor
United States
MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)Recruiting
NCT07431827Phase 3Updated Jul 24, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
Argentina, Australia, Canada, China, France +8 more
A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 MutationsSuspended
NCT05378763Phase 3Updated Jul 24, 2026
Sponsor: Spectrum Pharmaceuticals, Inc
NSCLC
United States
Navigation Bronchoscopy Guided Microwave Ablation Versus SBRT in Early NSCLCNot Yet Recruiting
NCT07722182Phase 2Updated Jul 24, 2026
Sponsor: Chinese University of Hong Kong
Lung Cancer (NSCLC)
Hong Kong
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR TrialRecruiting
NCT04402788Phase 2, Phase 3Updated Jul 24, 2026
Sponsor: National Cancer Institute (NCI)
Extensive Stage Lung Small Cell Carcinoma
United States
Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)Active Not Recruiting
NCT00002540NAUpdated Jul 24, 2026
Sponsor: National Cancer Institute (NCI)
Prostate Carcinoma
United States
Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain MetastasesRecruiting
NCT07511933NAUpdated Jul 24, 2026
Sponsor: The Netherlands Cancer Institute
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) · Brain Metastases From Melanoma · Brain Metastases From Breast Cancer
Netherlands

Previous page Next page